bearish
The Odd Timing of the Final Rule on Samsung Biologics and Firing of Kim Dong-Yeon & Jang Ha-Sung
346 Views12 Nov 2018 12:19
It was reported in numerous local Korean media today that the final decision by the regulators on the fate of Samsung Biologics Co., (207940...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Samsung Biologics: A Temporary Suspension of Shares Trading14 Nov 2018
- The Odd Timing of the Final Rule on Samsung Biologics and Firing of Kim Dong-Yeon & Jang Ha-Sung12 Nov 2018
- Samsung BioLogics Update22 Oct 2018
- Samsung Biologics: Regulators Crack Down On Its Accounting12 Jul 2018
- FSC Chairman Speaks on Decision Framework25 May 2018
x